What you do in that window matters
PlexusDx maintains partnerships across multiple licensed 503A compounding networks and actively monitors regulatory developments
Ipamorelin was placed on the FDA Category 2 list in late 2023, banning compounding pharmacies from producing it
"I haven't seen convincing evidence that any of these will make a significant impact on weight loss," Dr
Compounded GLP-1s are a glucagon-like peptide-1 (GLP-1) receptor agonist which may be used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
I eat based on the evolutionary framework, and I dont think our ancestors chose their meal sizes because of the time of day